Transitional care intervention for Alzheimer's patients and their caregivers
Transitional Care for Skilled Nursing Facility Patients With Alzheimer's Disease and Related Dementias and Their Caregivers: a Cluster Randomized Trial
NA · University of North Carolina, Chapel Hill · NCT06840587
This study tests a new program to help Alzheimer's patients and their caregivers adjust better when moving from nursing homes to home or other care settings.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 360 (estimated) |
| Ages | 19 Years and up |
| Sex | All |
| Sponsor | University of North Carolina, Chapel Hill (other) |
| Locations | 1 site (Chapel Hill, North Carolina) |
| Trial ID | NCT06840587 on ClinicalTrials.gov |
What this trial studies
This study tests the efficacy of the Connect-Home ADRD intervention, which aims to support patients with Alzheimer's disease and related dementias (ADRD) and their caregivers during transitions from Skilled Nursing Facilities (SNFs) to home or other care settings. It employs a cluster randomized trial design involving 12 SNFs in North Carolina, where half will receive the intervention and half will serve as a control group. The primary goals are to reduce caregiver strain and improve patient neuropsychiatric symptoms through structured support from Dementia Caregiving Specialists.
Who should consider this trial
Good fit: Ideal candidates include English-speaking patients diagnosed with dementia who are transitioning to home, assisted living, or long-term care, along with their willing caregivers.
Not a fit: Patients who are planned for hospital readmission within 30 days post-enrollment may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly alleviate caregiver burden and improve the quality of life for patients with Alzheimer's and related dementias.
How similar studies have performed: Other studies have shown promise in transitional care interventions for dementia patients, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients: * Ability to speak English * Goal of discharge to home, assisted living, or long-term care * Diagnosis of dementia * Having a caregiver willing to participate Caregivers: * Ability to speak English * Legally authorized representative (LAR) who also provides support for the person with ADRD Inclusion criteria for SNFs: * Location within 120 miles of UNC-Chapel Hill * Admission of at least 75 SNF patients per year Exclusion Criteria: Patients: * Planned hospital readmission for procedures or treatments within 30 days post enrollment. Caregivers: * LAR is a court-appointed guardian.
Where this trial is running
Chapel Hill, North Carolina
- University of North Carolina at Chapel Hill — Chapel Hill, North Carolina, United States (RECRUITING)
Study contacts
- Principal investigator: Mark Toles, PhD, RN — University of North Carolina, Chapel Hill
- Study coordinator: Molly Lynch, MS
- Email: molly_lynch@unc.edu
- Phone: 9198438874
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Alzheimer Disease, Dementia